Peripheral blood and bone marrow requirements for complete (CR) and partial (PR) remissions as well as other remission categories in myelofibrosis with myeloid metaplasia (MMM) and myelodysplastic syndrome (MDS)
. | IWG-MMM . | . | IWG-MDS . | . | EUMNET-MMM . | . | |||
---|---|---|---|---|---|---|---|---|---|
Response category . | Peripheral blood . | Bone marrow . | Peripheral blood . | Bone marrow . | Peripheral blood . | Bone marrow . | |||
Complete remission (CR) | Hgb ≥ 110 g/L Platelets ≥ 100 × 109/L Neutrophils ≥ 1.0 × 109/L All counts ≤ upper normal limit No blasts or immature cells | Blasts ≤ 5% Fibrosis grade ≤ 1 Normocellular | Hgb ≥ 110 g/L Platelets ≥ 100 × 109/L Neutrophils ≥ 1.0 × 109/L No blasts | Blasts ≤ 5% Dysplasia allowed | N/A | N/A | |||
Partial remission (PR) | Hgb ≥ 110 g/L Platelets ≥ 100 × 109/L Neutrophils ≥ 1.0 × 109/L All counts ≤ upper normal limit No blasts or immature cells | Not relevant | Hgb ≥ 110 g/L Platelets ≥ 100 × 109/L Neutrophils ≥ 1.0 × 109/L No blasts | Blasts > 5% but ≥ 50% ↓ in number | N/A | N/A | |||
Marrow CR | N/A | N/A | Not relevant | Blasts ≤ 5% and ≥ 50% ↓ in number Dysplasia allowed | N/A | N/A | |||
Clinical improvement | Table 1 | Not relevant | N/A | N/A | N/A | N/A | |||
Hematologic improvement | N/A | N/A | Cheson et al32 | Not relevant | N/A | N/A | |||
Complete response | N/A | N/A | N/A | N/A | Table 3 | Not relevant | |||
Major response | N/A | N/A | N/A | N/A | Table 3 | Not relevant | |||
Moderate response | N/A | N/A | N/A | N/A | Table 3 | Not relevant | |||
Minor response | N/A | N/A | N/A | N/A | Table 3 | Not relevant |
. | IWG-MMM . | . | IWG-MDS . | . | EUMNET-MMM . | . | |||
---|---|---|---|---|---|---|---|---|---|
Response category . | Peripheral blood . | Bone marrow . | Peripheral blood . | Bone marrow . | Peripheral blood . | Bone marrow . | |||
Complete remission (CR) | Hgb ≥ 110 g/L Platelets ≥ 100 × 109/L Neutrophils ≥ 1.0 × 109/L All counts ≤ upper normal limit No blasts or immature cells | Blasts ≤ 5% Fibrosis grade ≤ 1 Normocellular | Hgb ≥ 110 g/L Platelets ≥ 100 × 109/L Neutrophils ≥ 1.0 × 109/L No blasts | Blasts ≤ 5% Dysplasia allowed | N/A | N/A | |||
Partial remission (PR) | Hgb ≥ 110 g/L Platelets ≥ 100 × 109/L Neutrophils ≥ 1.0 × 109/L All counts ≤ upper normal limit No blasts or immature cells | Not relevant | Hgb ≥ 110 g/L Platelets ≥ 100 × 109/L Neutrophils ≥ 1.0 × 109/L No blasts | Blasts > 5% but ≥ 50% ↓ in number | N/A | N/A | |||
Marrow CR | N/A | N/A | Not relevant | Blasts ≤ 5% and ≥ 50% ↓ in number Dysplasia allowed | N/A | N/A | |||
Clinical improvement | Table 1 | Not relevant | N/A | N/A | N/A | N/A | |||
Hematologic improvement | N/A | N/A | Cheson et al32 | Not relevant | N/A | N/A | |||
Complete response | N/A | N/A | N/A | N/A | Table 3 | Not relevant | |||
Major response | N/A | N/A | N/A | N/A | Table 3 | Not relevant | |||
Moderate response | N/A | N/A | N/A | N/A | Table 3 | Not relevant | |||
Minor response | N/A | N/A | N/A | N/A | Table 3 | Not relevant |
The International Working Group (IWG) response criteria for MMM and MDS are compared with each other as well as with the criteria set by the European Myelofibrosis Network (EUMNET) for MMM.
Hgb indicates hemoglobin level; N/A, not applicable